As shown in Supplementary Figure 7, group 1 curve crossed group 2 curve from 30 to 60 months, which means the combination of SLC2A1 and SLC2A2 might not be able to discriminate prognosis of HCC patients. Here, SLC2A2 is linked to hepatocellular carcinoma.